In early April, the IRS released its 10-year strategic operating plan, a document that includes 42 key initiatives and 190 projects intended to transform how the agency delivers tax services. As part ...

Luminar has collaborated with multiple leading global OEMs including to develop a collective industry standard for LiDAR, which will cover all use cases from advanced safety through full autonomy, ...

(1) See "Definitions of non-GAAP Measures and Metrics as Calculated by the Company" above. View original content to download multimedia:https://www.prnewswire.com ...

PHOENIX--(BUSINESS WIRE)-- Carvana Co. (NYSE: CVNA), the leading e-commerce platform for buying and selling used cars, presented today at the William Blair 44th Annual Growth Stock Conference, sharing ...

RENO, Nevada, Nov. 12, 2024 /PRNewswire/ - i-80 GOLD CORP. (IAUX) ("i-80 Gold", or the "Company") reports its operating and financial results for the three and nine months ended September 30, 2024.

OKLAHOMA CITY, Oct. 29, 2024 (GLOBE NEWSWIRE) -- Expand Energy Corporation (NASDAQ: EXE) (“Expand Energy” or the “company”) today reported third quarter 2024 financial and operating results. In ...

On September 28, the OCC’s Committee on Bank Supervision released its bank supervision operating plan for fiscal year 2024. The plan outlines the agency’s supervision priorities and highlights several ...

The purpose of a business plan is to communicate the vision and operating plan for your business. In this guide, we’ll look at how to write a strong business plan to guide your business decisions, get ...

ST. LOUIS — The MetroLink has made operational changes after hearing from riders. Starting Monday, Dec. 4, during the day and normal hours it will be exactly like it was before. The plan follows the ...

FDA accepted NDA for zidesamtinib for the treatment of TKI pre-treated patients with advanced ROS1-positive NSCLC; PDUFA target action date of September 18, 2026 NDA submission for neladalkib in TKI ...

FDA accepted NDA for zidesamtinib for the treatment of TKI pre-treated patients with advanced ROS1-positive NSCLC; PDUFA target action date of September 18, 2026 NDA submission for neladalkib in TKI ...